← Back to headlines
UBS Cuts Boston Scientific Target Price While Maintaining 'Buy' Rating
UBS has reportedly cut its target price for Boston Scientific but continues to recommend the stock as a 'buy'.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
16m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
24m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
45m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
52m ago